ESMO Congress 2025

Meet us at ESMO 2025 – Standing by those who care about cancer!

October 17-21, Berlin will be the heart of innovation and collaboration. The ESMO Congress gathers over 25,000 global experts in oncology to share, challenge, and shape the future of cancer care

‍At the center of progress: Actionable Biomarkers.

Actionable biomarkers analysis has a major clinical impact. It is a guide for clinicians toward more precise, personalized, and impactful therapies.
BIOTYPE’s mission is to empower decision-making through robust, rapid, and comprehensive molecular profiling across key tumor entities:

• Breast cancer
• Endometrial cancer
• Bladder cancer

Join Dr. Abhishek Aich, Dr. Rebekka Weißbach, and Vanessa Grunwald at ESMO 2025 to explore how BIOTYPE’s solutions can support your clinical goals - today and in the future.

Let’s connect via LinkedIn and schedule a meeting! We would be happy to arrange a personal meeting during the event – please, contact us via LinkedIn or email.

Together, let’s turn data into decisions - and decisions into better outcomes.

‍